Overview

The company accelerates the promise of molecular medicine by focusing on the development and commercialization of targeted radiolabeled and molecular imaging pharmaceuticals for use in oncology. Its products will intend to improve the lives of patients through timely and accurate detection, effective monitoring of therapeutic response, disease progression and an improved treatment.